Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2

Authors Einav Tayeb-Fligelman, Xinyi Cheng, Christen Tai, Jeannette T. Bowler, Sarah Griner, Michael R. Sawaya, Paul M. Seidler, Yi Xiao Jiang, Jiahui Lu, Gregory M. Rosenberg, Lukasz Salwinski, Romany Abskharon, Chih-Te Zee, Ke Hou, Yan Li, David Boyer, Kevin A. Murray, Genesis Falcon, Daniel H. Anderson, Duilio Cascio, Lorena Saelices, Robert Damoiseaux, Feng Guo, David Eisenberg
Details bioRxiv. March 18, 2021
DOI 10.1101/2021.03.05.434000
Source View on BioRxiv

Join the conversation

Create an Account or Sign In to comment.
1 Comment threads
0 Thread replies
Most reacted comment
Hottest comment thread
1 Comment authors
Jill Bouchard Recent comment authors
newest oldest most voted
Jill Bouchard
Jill Bouchard
Managing editor,

Nice–designing peptide inhibitors that target the zipper driving phase separation may be an option for therapeutic intervention.